PsyBio Therapeutics Successfully Completes First Pre-IND Meeting with the United States...

Mydecine Files Full Patent Application Covering Multiple Families of Psilocin Analogs

Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug...

PTSF88 – Dr. Ben Sessa of Awakn Life Sciences + Josh...

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...

Editor’s Choice Award 2021-Best Study on Psychedelics and Pharmacology

MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of...

Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products...

Delix Therapeutics Partners with the National Institute on Drug Abuse (NIDA)...

Psilera Confirms PSIL-002, A New DMT Derivative, is Well-Tolerated and Non-Hallucinogenic...

Load more